Thomas J Jacques, MD
Anesthesiology · Fresno
- Medicare standing
- Clear
- Enrolled, allowed to bill and order, not excluded
- Plans that list them
- Not verified
- Not the same as out of network.
- Offices
- 4
Offices
4 locations · Integrated Pain Management Medical Group Inc · 42 clinicians in this group
Plan participation
Not verified
We could not verify current plan participation for this doctor. This does not mean they are out of network. Call Dr. Jacques’s office to ask if they take your plan before you enroll.
California Medical Board record
Licence A104289 · Current
Licensed to practise in California · since 2008 · expires 2028-04-30 · University of Wisconsin Medical School.
No disciplinary actions, convictions, malpractice judgments or citations in this record.
Medicaid work
$679 in 2023
Medicaid paid $679 for 253 billed services this clinician did in 2023, up to 52 people in a month for one service.
Medicaid and CHIP claims where this clinician did the service, fee-for-service and managed care together. Any month with fewer than 11 patients is hidden, so small Medicaid practices undercount.
| Injection(s), diagnostic or therapeutic agent, paravertebral facet (zygapophyseal) joint (or nerves innervating that joint) with image guidance (fluoroscopy or CT), lumbar or sacral; single level | 42 | $195 |
| Destruction by neurolytic agent, paravertebral facet joint nerve(s), with imaging guidance (fluoroscopy or CT); lumbar or sacral, single facet joint | 14 | $176 |
| Injection(s), diagnostic or therapeutic agent, paravertebral facet (zygapophyseal) joint (or nerves innervating that joint) with image guidance (fluoroscopy or CT), lumbar or sacral; second level (List separately in addition to code for primary procedure) | 38 | $131 |
| Destruction by neurolytic agent, paravertebral facet joint nerve(s), with imaging guidance (fluoroscopy or CT); lumbar or sacral, each additional facet joint (List separately in addition to code for primary procedure) | 15 | $92 |
| Moderate sedation services provided by the same physician or other qualified health care professional performing the diagnostic or therapeutic service that the sedation supports, requiring the presence of an independent trained observer to assist in the monitoring of the patient's level of consciousness and physiological status; initial 15 minutes of intraservice time, patient age 5 years or older | 54 | $84 |
| Injection(s), anesthetic agent(s) and/or steroid; transforaminal epidural, with imaging guidance (fluoroscopy or CT), lumbar or sacral, single level | 23 | $0 |
| Injection, dexamethasone sodium phosphate, 1 mg | 16 | $0 |
| Unclassified drugs | 51 | $0 |
| 2023 | 253 | 8 | 52 | $679 |
| 2021 | 792 | 15 | 184 | $2,990 |
| 2020 | 19,391 | 29 | 718 | $206,736 |
| 2019 | 4,541 | 29 | 415 | $134,009 |
| 2018 | 927 | 12 | 36 | $57,073 |
See the largest Medicaid services in earlier years
2021
| Return visit (30+ min) | 225 | $974 |
| Destruction by neurolytic agent, paravertebral facet joint nerve(s), with imaging guidance (fluoroscopy or CT); lumbar or sacral, single facet joint | 24 | $648 |
| Injection(s), diagnostic or therapeutic agent, paravertebral facet (zygapophyseal) joint (or nerves innervating that joint) with image guidance (fluoroscopy or CT), lumbar or sacral; single level | 80 | $478 |
| Telehealth originating site facility fee | 12 | $303 |
| Short return visit (20+ min) | 107 | $275 |
| Destruction by neurolytic agent, paravertebral facet joint nerve(s), with imaging guidance (fluoroscopy or CT); lumbar or sacral, each additional facet joint (List separately in addition to code for primary procedure) | 24 | $123 |
| Injection(s), diagnostic or therapeutic agent, paravertebral facet (zygapophyseal) joint (or nerves innervating that joint) with image guidance (fluoroscopy or CT), cervical or thoracic; single level | 19 | $101 |
| Telehealth transmission, per minute, professional services bill separately | 12 | $48 |
| Handling and/or conveyance of specimen for transfer from physician office to laboratory | 111 | $41 |
| Injection(s), anesthetic agent(s) and/or steroid; transforaminal epidural, with imaging guidance (fluoroscopy or CT), lumbar or sacral, single level | 20 | $0 |
| Injection(s), diagnostic or therapeutic agent, paravertebral facet (zygapophyseal) joint (or nerves innervating that joint) with image guidance (fluoroscopy or CT), cervical or thoracic; second level (List separately in addition to code for primary procedure) | 19 | $0 |
| Injection(s), diagnostic or therapeutic agent, paravertebral facet (zygapophyseal) joint (or nerves innervating that joint) with image guidance (fluoroscopy or CT), lumbar or sacral; second level (List separately in addition to code for primary procedure) | 83 | $0 |
2020
| Return visit (30+ min) | 6,920 | $59,211 |
| Injection(s), diagnostic or therapeutic agent, paravertebral facet (zygapophyseal) joint (or nerves innervating that joint) with image guidance (fluoroscopy or CT), lumbar or sacral; single level | 1,166 | $17,719 |
| Short return visit (20+ min) | 1,074 | $14,863 |
| Injection(s), diagnostic or therapeutic agent, paravertebral facet (zygapophyseal) joint (or nerves innervating that joint) with image guidance (fluoroscopy or CT), lumbar or sacral; second level (List separately in addition to code for primary procedure) | 1,140 | $13,267 |
| Moderate sedation services provided by the same physician or other qualified health care professional performing the diagnostic or therapeutic service that the sedation supports, requiring the presence of an independent trained observer to assist in the monitoring of the patient's level of consciousness and physiological status; initial 15 minutes of intraservice time, patient age 5 years or older | 1,054 | $12,981 |
| Psychological or neuropsychological test administration and scoring by technician, two or more tests, any method; first 30 minutes | 731 | $11,250 |
| Destruction by neurolytic agent, paravertebral facet joint nerve(s), with imaging guidance (fluoroscopy or CT); lumbar or sacral, single facet joint | 306 | $11,023 |
| Chronic care management services with the following required elements: multiple (two or more) chronic conditions expected to last at least 12 months, or until the death of the patient, chronic conditions that place the patient at significant risk of death, acute exacerbation/decompensation, or functional decline, comprehensive care plan established, implemented, revised, or monitored; first 20 minutes of clinical staff time directed by a physician or other qualified health care professional, per calendar month. | 441 | $9,595 |
| Telehealth originating site facility fee | 514 | $8,762 |
| Injection(s), anesthetic agent(s) and/or steroid; transforaminal epidural, with imaging guidance (fluoroscopy or CT), lumbar or sacral, single level | 354 | $5,690 |
| New patient visit (30+ min) | 462 | $5,482 |
| New patient visit (45+ min) | 170 | $5,470 |
2019
| NJX INTERLAMINAR LMBR/SAC | 208 | $49,222 |
| Return visit (30+ min) | 1,482 | $24,214 |
| Short return visit (20+ min) | 357 | $16,102 |
| Service | 102 | $8,256 |
| Service | 59 | $4,690 |
| Injection procedure for sacroiliac joint, anesthetic/steroid, with image guidance (fluoroscopy or CT) including arthrography when performed | 12 | $4,641 |
| Injection(s), diagnostic or therapeutic agent, paravertebral facet (zygapophyseal) joint (or nerves innervating that joint) with image guidance (fluoroscopy or CT), lumbar or sacral; single level | 123 | $4,622 |
| X-ray of lumbosacral spine, anteroposterior and lateral views | 305 | $3,648 |
| Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 15-21 drug class(es), including metabolite(s) if performed | 24 | $3,188 |
| Drug test(s), presumptive, any number of drug classes, any number of devices or procedures; capable of being read by direct optical observation only (eg, utilizing immunoassay [eg, dipsticks, cups, cards, or cartridges]), includes sample validation when performed, per date of service | 106 | $3,150 |
| Moderate sedation services provided by the same physician or other qualified health care professional performing the diagnostic or therapeutic service that the sedation supports, requiring the presence of an independent trained observer to assist in the monitoring of the patient's level of consciousness and physiological status; initial 15 minutes of intraservice time, patient age 5 years or older | 148 | $3,078 |
| Injection(s), anesthetic agent(s) and/or steroid; transforaminal epidural, with imaging guidance (fluoroscopy or CT), lumbar or sacral, single level | 48 | $2,309 |
2018
| NJX INTERLAMINAR LMBR/SAC | 80 | $22,608 |
| Return visit (30+ min) | 109 | $8,719 |
| Service | 92 | $8,361 |
| Injection(s), anesthetic agent(s) and/or steroid; transforaminal epidural, with imaging guidance (fluoroscopy or CT), lumbar or sacral, single level | 13 | $4,378 |
| Service | 91 | $3,317 |
| Service | 91 | $1,946 |
| OFFICE/OP CONSLTJ NEW/EST PT LOW MDM 30 MINUTES | 14 | $1,826 |
| Short return visit (20+ min) | 39 | $1,825 |
| X-ray of lumbosacral spine, anteroposterior and lateral views | 198 | $1,682 |
| Service | 92 | $1,507 |
| Sterile water/saline, 500 ml | 91 | $492 |
| Drug test(s), presumptive, any number of drug classes, any number of devices or procedures; capable of being read by direct optical observation only (eg, utilizing immunoassay [eg, dipsticks, cups, cards, or cartridges]), includes sample validation when performed, per date of service | 17 | $411 |
Drugs they prescribed that Part D paid
$955
Pharmacies billed $955 in 2024.
This is pharmacy cost, not the office bill, and not what patients paid.
Opioids were 0% of their Part D prescriptions (0 of 66) in 2024. At or below the middle of the specialty; the typical anesthesiology clinician is at 0%.
65 generic and fewer than 11 brand-name prescriptions · $955 in drug cost.
Part D prescriptions only. The opioid rate is opioid prescriptions as a share of all this clinician's Part D prescriptions; surgeons and pain specialists run higher than others, so it is shown against the same specialty.
| Lidocaine | 11 | $749 | $68 |
| Ibuprofen | 17 | $72 | $4 |
| Cyclobenzaprine | 15 | $19 | $1 |
Year by year
| 2024 | 66 | 19 | 0% (0) | None | $955 |
| 2023 | 35 | 16 | 0% (0) | 0% | $498 |
| 2020 | 42 | 30 | None | None | $1,410 |
| 2019 | 2,126 | 406 | 79% (1,682) | 10% | $128,700 |
| 2018 | 602 | 161 | 57% (342) | 13% | $43,988 |
| 2017 | 855 | 150 | 52% (440) | 10% | $40,399 |
| 2016 | 960 | 128 | 52% (499) | 12% | $52,272 |
| 2015 | 335 | 76 | 67% (224) | 5% | $13,275 |
| 2014 | 105 | 33 | 51% (53) | None | $3,593 |
| 2013 | 575 | 188 | 58% (332) | 10% | $30,874 |
Part D prescriptions only. A drug prescribed to fewer than 11 people in a year is hidden.
See the drugs prescribed each year
2020: 1 drug
| Cephalexin | 17 | $79 | $5 |
2019: 25 drugs
| Hydrocodone-Acetaminophen | 700 | $17,139 | $24 |
| Oxycodone-Acetaminophen | 289 | $15,164 | $52 |
| Oxycontin | 23 | $14,823 | $644 |
| Movantik | 36 | $13,605 | $378 |
| Lyrica | 22 | $13,104 | $596 |
| Fentanyl | 87 | $6,655 | $76 |
| Morphine Sulfate Er | 213 | $6,299 | $30 |
| Nucynta Er | 13 | $5,580 | $429 |
| Buprenorphine | 19 | $4,724 | $249 |
| Gabapentin | 160 | $2,828 | $18 |
| Oxycodone | 104 | $2,667 | $26 |
| Tramadol Hcl Er | 25 | $1,854 | $74 |
| Diclofenac | 11 | $1,302 | $118 |
| Celecoxib | 13 | $1,202 | $92 |
| Morphine Sulfate | 26 | $686 | $26 |
| Methadone | 46 | $652 | $14 |
| Hydromorphone | 44 | $515 | $12 |
| Tizanidine | 39 | $512 | $13 |
| Cyclobenzaprine | 42 | $300 | $7 |
| Tramadol | 42 | $241 | $6 |
| Acetaminophen-Codeine | 14 | $231 | $17 |
| Ibuprofen | 16 | $146 | $9 |
| Trazodone | 15 | $128 | $9 |
| Methocarbamol | 11 | $123 | $11 |
| Cephalexin | 13 | $80 | $6 |
2018: 10 drugs
| Lyrica | 32 | $17,320 | $541 |
| Hydrocodone-Acetaminophen | 184 | $3,559 | $19 |
| Oxycodone-Acetaminophen | 41 | $1,550 | $38 |
| Morphine Sulfate Er | 30 | $1,022 | $34 |
| Gabapentin | 70 | $935 | $13 |
| Oxycodone | 20 | $428 | $21 |
| Duloxetine | 11 | $390 | $35 |
| Tizanidine | 16 | $217 | $14 |
| Cyclobenzaprine | 18 | $180 | $10 |
| Tramadol | 13 | $45 | $3 |
2017: 14 drugs
| Lyrica | 36 | $16,798 | $467 |
| Hydrocodone-Acetaminophen | 233 | $4,177 | $18 |
| Gabapentin | 99 | $1,902 | $19 |
| Oxycodone-Acetaminophen | 49 | $1,890 | $39 |
| Morphine Sulfate Er | 57 | $1,807 | $32 |
| Duloxetine | 33 | $1,157 | $35 |
| Voltaren | 12 | $630 | $52 |
| Oxycodone | 26 | $534 | $21 |
| Tizanidine | 45 | $443 | $10 |
| Cyclobenzaprine | 32 | $324 | $10 |
| Tramadol | 26 | $164 | $6 |
| Ibuprofen | 26 | $104 | $4 |
| Famotidine | 16 | $56 | $3 |
| Ibu | 11 | $55 | $5 |
2016: 21 drugs
| Lyrica | 31 | $11,102 | $358 |
| Movantik | 30 | $8,624 | $287 |
| Hydrocodone-Acetaminophen | 249 | $6,093 | $24 |
| Oxycodone-Acetaminophen | 59 | $3,567 | $60 |
| Oxycontin | 15 | $2,545 | $170 |
| Gabapentin | 88 | $2,128 | $24 |
| Duloxetine | 36 | $1,722 | $48 |
| Naproxen | 14 | $1,550 | $111 |
| Morphine Sulfate Er | 43 | $1,545 | $36 |
| Tramadol Hcl Er | 11 | $1,324 | $120 |
| Oxycodone | 30 | $855 | $28 |
| Tizanidine | 31 | $712 | $23 |
| Celecoxib | 12 | $694 | $58 |
| Tramadol | 45 | $263 | $6 |
| Ibuprofen | 38 | $234 | $6 |
| Baclofen | 21 | $230 | $11 |
| Cyclobenzaprine | 27 | $202 | $7 |
| Famotidine | 17 | $141 | $8 |
| Omeprazole | 16 | $126 | $8 |
| Meloxicam | 12 | $112 | $9 |
| Trazodone | 22 | $91 | $4 |
2015: 7 drugs
| Hydrocodone-Acetaminophen | 124 | $3,193 | $26 |
| Oxycodone-Acetaminophen | 25 | $1,654 | $66 |
| Morphine Sulfate Er | 18 | $889 | $49 |
| Naproxen | 14 | $606 | $43 |
| Gabapentin | 19 | $393 | $21 |
| Tramadol | 32 | $233 | $7 |
| Ibuprofen | 11 | $79 | $7 |
2014: 3 drugs
| Hydrocodone-Acetaminophen | 26 | $500 | $19 |
| Ibuprofen | 13 | $131 | $10 |
| Tramadol | 11 | $73 | $7 |
2013: 14 drugs
| Opana Er | 24 | $8,994 | $375 |
| Lidoderm | 14 | $5,382 | $384 |
| Oxycodone Hcl-Acetaminophen | 51 | $2,844 | $56 |
| Hydrocodone-Acetaminophen | 91 | $2,402 | $26 |
| Morphine Sulfate Er | 64 | $2,060 | $32 |
| Fentanyl | 21 | $2,047 | $97 |
| Tizanidine | 66 | $1,185 | $18 |
| Oxycodone | 25 | $865 | $35 |
| Gabapentin | 29 | $673 | $23 |
| Carisoprodol | 37 | $536 | $14 |
| Tramadol | 31 | $285 | $9 |
| Meloxicam | 15 | $123 | $8 |
| Ibuprofen | 15 | $121 | $8 |
| Cyclobenzaprine | 13 | $93 | $7 |
Money from drug and device companies
$200 in 2025
| 2025 | 1 | 19 | None | $200 |
| 2024 | 1 | 1 | None | $16 |
| 2022 | 3 | 8 | None | $800 |
| 2021 | 2 | 3 | None | $129 |
| 2020 | 1 | 17 | None | $535 |
| 2019 | 8 | 42 | None | $1,863 |
Paid work is consulting, speaking, honoraria and royalties, as opposed to meals and travel.
A payment is not proof that care is biased.
| Electronic Waveform Lab | None | $200 | 17 payments
|
See all 17 published payments
| Electronic Waveform Lab | Meals · 2025-12-16 | None | $1 |
| Electronic Waveform Lab | Meals · 2025-12-15 | None | $14 |
| Electronic Waveform Lab | Meals · 2025-11-21 | None | $6 |
| Electronic Waveform Lab | Meals · 2025-11-12 | None | $8 |
| Electronic Waveform Lab | Meals · 2025-10-28 | None | $25 |
| Electronic Waveform Lab | Meals · 2025-10-09 | None | $9 |
| Electronic Waveform Lab | Meals · 2025-09-17 | None | $21 |
| Electronic Waveform Lab | Meals · 2025-08-25 | None | $18 |
| Electronic Waveform Lab | Meals · 2025-08-21 | None | $8 |
| Electronic Waveform Lab | Meals · 2025-07-24 | None | $7 |
| Electronic Waveform Lab | Meals · 2025-06-30 | None | $10 |
| Electronic Waveform Lab | Meals · 2025-05-29 | None | $8 |
| Electronic Waveform Lab | Meals · 2025-05-16 | None | $8 |
| Electronic Waveform Lab | Meals · 2025-05-05 | None | $10 |
| Electronic Waveform Lab | Meals · 2025-04-16 | None | $8 |
| Electronic Waveform Lab | Meals · 2025-03-19 | None | $30 |
| Electronic Waveform Lab | Meals · 2025-02-28 | None | $8 |
See earlier years (2024, 2022, 2021, 2020, 2019)
2024: $16
| Abbvie | Botox | $16 | 1 payment
|
2022: $800
| Si-Bone | Ifuse Implant | $651 | 6 payments
|
| Medtronic | Vanta Adaptivestim | $122 | 1 payment
|
| Electronic Waveform Lab | None | $27 | 1 payment
|
2021: $129
| Medtronic | Intellis | $110 | 1 payment
|
| Stimwave Technologies | Stimq Receiver Stimulator Kit Channel A US W Receiver | $19 | 2 payments
|
2020: $535
| Abbott Laboratories | Proclaim Family of Scs Ipgs | $535 | 17 payments
|
2019: $1,863
| Medtronic USA | Adaptivestim | $786 | 7 payments
|
| Nevro | Senza Spinal Cord Stimulation System | $393 | 9 payments
|
| Boston Scientific | General Pain Management | $249 | 9 payments
|
| Abbott Laboratories | Proclaim Family of Scs Ipgs | $239 | 6 payments
|
| Daiichi Sankyo | Morphabond Er | $78 | 4 payments
|
| Collegium Pharmaceutical | Xtampza | $74 | 4 payments
|
| Pfizer | Lyrica | $26 | 2 payments
|
| TerSera Therapeutics | Prialt | $18 | 1 payment
|
Professional record
- NPI
- 1609006592
- Licence
- CA A104289, NV 13910California A104289: Current · expires 2028-04-30
- Trained
- University of Wisconsin School of Medicine, 2006
- Gender
- Male
More record details
- Sole proprietor
- No
- Medicaid ID
- NV 1609006592
- Taxonomy
- Federal specialty code 207L00000X (207L00000X); Federal specialty code 208VP0000X (208VP0000X)
- Mailing address
- 5771 N Fresno St, Fresno, CA, 93710
- NPI first listed
- 2009-07-25
- NPI last updated
- 2020-01-30
- NPI record certified
- 2020-01-30
This is when the NPI record was last certified, not a medical board exam.